Hemodynamic monitoring systems are used in hospitals, clinics, home care settings, ambulatory surgery centers, and independent catheterization laboratories. Some of these systems include, vital sign monitors, pulse oximeters, central venous catheters, non-invasive blood pressure monitors, and pulmonary artery catheters. The global hemodynamic monitoring system market is estimated to account for US$ 10,846.3 Mn in terms of value by the end of 2027.
Global Hemodynamic Monitoring System Market: Drivers
Increasing prevalence of congenital heart disease is expected to propel growth of the global hemodynamic monitoring system market over the forecast period. For instance, according to the study, Prevalence, profile, and pattern of congenital heart disease in Central India: A prospective, observational study (published in May 2018), the prevalence of congenital heart disease (CHD) was 10.13/1000 live births.
Global Hemodynamic Monitoring System Market: Opportunities
The use of the deep-learning method to build certain kinds of prediction model is increasing in the medical field. Therefore, key players in the market can focus on integrating deep-learning method to enhance stroke volume (SV) estimation by arterial blood pressure.
Global Hemodynamic Monitoring System Market: Restraints
However, use of hemodynamic monitoring systems is associated with complications such as dysrhythmias, balloon rupture, knotting of the catheter, infection, pulmonary infarction, pulmonary artery rupture, and deep vein thrombosis, which is expected to hamper growth of the market.
The Pulse Oximeters segment in the global hemodynamic monitoring system market was valued at US$ 718.0 Mn in 2018 and is expected to reach US$ 1,078.6 Mn by 2027 at a CAGR of 13.4% during the forecast period. The growth of the segment is attributed to increasing patient population suffering from chronic diseases The Invasive Hemodynamic Monitoring segment held dominant position in the global hemodynamic monitoring system market in 2018, accounting for 49.4% share in terms of volume, followed by Non-Invasive Hemodynamic Monitoring, and Minimally Invasive Hemodynamic Monitoring, respectively. Technological advancement and increasing product approvals is anticipated to propel the growth of the segment during the forecast period
The preference for home care settings compared to hospitals is increasing due to growing concerns over the aging population and relatively high costs incurred during hospitalization of people suffering from chronic illness. Key players in the market are focused on developing single monitoring platform. For instance, in July 2019, Caretaker Medical partnered with Mespere LifeSciences to integrate wireless CNIBP, Cerebral Oximetry, and other non-invasive hemodynamic measurements in a single monitoring platform.
Global Hemodynamic Monitoring System Market: Competitive Landscape
Major players operating in the global hemodynamic monitoring system market include, Edwards Lifesciences Corporation, ICU Medical, Inc., PULSION Medical Systems SE, Koninklijke Philips N.V., General Electric Company, OMRON Corporation, B. Braun Melsungen AG, LIDCO Ltd., Medtronic, Inc., Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation, Schwarzer Cardiotek GmbH, Osypka Medical GmbH, and Tensys Medical Inc.
Global Hemodynamic Monitoring System Market: Key Developments
Scope of the report
“*” marked represents similar segmentation in other categories in the respective section.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.